Ligand validation:8ZOZ

AMP: ADENOSINE MONOPHOSPHATE

AMP is a Ligand Of Interest in 8ZOZ designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8ZOZ_AMP_A_401	38%	62%	0.198	0.901	0.67	0.8	-	-	0	0	100%	1
8ZOZ_AMP_C_401	35%	59%	0.167	0.852	0.71	0.87	-	1	1	0	100%	1
8ZOZ_AMP_D_401	31%	61%	0.231	0.898	0.59	0.88	-	2	0	0	100%	1
8ZOZ_AMP_B_401	17%	63%	0.234	0.812	0.65	0.76	-	-	0	0	100%	1
9IJ6_AMP_D_401	71%	58%	0.123	0.945	0.69	0.91	-	1	1	0	100%	1
7SNB_AMP_A_303	100%	55%	0.045	0.993	0.75	0.98	-	1	0	0	100%	0.783
3CLT_AMP_C_1262	100%	40%	0.046	0.987	0.91	1.4	1	4	0	0	100%	1
3CLR_AMP_C_1262	100%	41%	0.048	0.989	1.01	1.29	1	3	0	0	100%	1
5K99_AMP_D_101	99%	36%	0.05	0.988	1.13	1.4	2	1	0	0	100%	0.9278
5NRH_AMP_B_700	99%	34%	0.051	0.989	1.23	1.39	3	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.